Indonesian health coalition demands return of protections against patent evergreening
The Coalition for Patient Rights Advocacy for Access to Medicines is pursuing a judicial review of the 2024 Indonesian Patent Law, calling for the return of crucial protections against patent evergreening.
Johnson & Johnson’s TB drug deal will fail to reach all those in need
A recent deal struck between Johnson & Johnson and the Global Drug Facility promises improved access to bedaquiline in a number of low income countries, but fails to address structural problems
Sí, podemos impedir que las patentes obstaculicen el tratamiento de la tuberculosis
Un día antes del Día Mundial de la Tuberculosis, la Oficina de Patentes de la India rechazó la solicitud del gigante farmacéutico Jannsen de prorrogar la patente del medicamento bedaquilina.
Yes, we can stop patents getting in the way of TB treatment
A day ahead of World TB Day, the Indian Patent Office rejected pharma giant Jannsen’s application for a patent extension on drug bedaquiline. If the patent had been extended, public and family budgets would have remained burdened by unjustifiably high costs of the drug
- Brazil approves end to 6×1 work schedule and reduction of the work week to 40 hours
- Israel kills 31 people in Lebanon on the eve of Eid al-Adha
- Israel carries out sixth consecutive Eid massacre in Gaza
- Far-right Janez Janša to return for fourth government term in Slovenia
- With peace deal nearly final, US launches fresh attacks on Iran
